Discover Armor Pharma’s Latest Addition: Lactose Monohydrate 100M

15. January 2026

Press Release 10 December 2025 - Armor Pharma is proud to introduce its 100M, a lactose monohydrate sieved grade, a...

Simultaneous evaluation of drug absorption and in vivo release behavior from coated mini tablets with Eudragit L 30 D-55 in rats using near-infrared imaging

15. January 2026

We previously demonstrated the use of near-infrared (NIR) imaging to evaluate differences in disintegration for various capsule formulations after oral...

Quantitative evaluation of transient pressure fluctuation behavior in jump tests applied to pharmaceutical powder materials

9. January 2026

Abstract Strain-rate sensitivity in certain metallic materials results from the interplay between two opposing mechanisms: positive strain-rate sensitivity (PSRS), wherein...

Quantifying the intrinsic effects of lubrication to predict the tensile strength of pharmaceutical formulations

7. January 2026

A new model was developed to predict the tensile strength of tablets compressed from a lubricated dry powder blend by...

Data-efficient prediction in tableting using word embeddings and empirically-guided neural networks

22. December 2025

Abstract The development of robust oral tablet formulations remains time-consuming, often limited by scarce data and the difficulty of incorporating...

Improved Dissolution of Poorly Water-Soluble Rutin via Solid Dispersion Prepared Using a Fluid-Bed Coating System

21. December 2025

Abstract Background/Objectives: Rutin, a bioactive flavonol glycoside known for its antioxidant, anti-inflammatory, and anticancer activities, faces limited clinical application due...

poster - Application of Novel Partially Pregelatinized Cassava [tapioca] Starch as Substitute Filler-Diluent

Application of Novel Partially Pregelatinized Cassava [tapioca] Starch as Substitute Filler-Diluent to Lactose in Personalized Substance-Abuse Therapy for Lactose Intolerant Population

17. December 2025

This poster was presented at the AAPS 2025 by GRIFFIN GAMMA LLC PURPOSE A study protocol was developed to evaluate...

Understanding excipient interactions unlocks untapped potential of RNA-lipid nanoparticles in dry powder formulations for local pulmonary delivery

16. December 2025

Abstract Small interfering RNA (siRNA)-loaded lipid nanoparticles (LNPs) are a promising modality for gene silencing therapies. Pulmonary delivery offers an...

An integrated analytical approach to evaluate powder aggregation and predict the aerodynamic performance of homogeneous powders

10. December 2025

Abstract Dry Powder Inhaler (DPI) formulations generally consist of drug particles with a size between 1 and 5 µm, ideal for...

Modeling of physical-mechanical and microbiological properties of tablets made of complex fluidized bed granules containing living yeast cells using common mixing rules

19. November 2025

Abstract In order to administer probiotic microorganisms effectively, suitable dosage forms and production methods are required. These must be geared...

Lactose